ReviewFrontiers in endocrinology2025

Teprotumumab in the management of thyroid eye disease mechanistic insights and adverse reactions: a comprehensive review.

Zhibin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.